51 – 60 of 1023
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
- Contribution to journal › Article
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping
- Contribution to journal › Article
-
Mark
A single-cell transcriptomic study of heterogeneity in human embryonic tanycytes
- Contribution to journal › Article
-
Mark
Spatial tumor immune microenvironment phenotypes in ovarian cancer
- Contribution to journal › Article
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
- Contribution to journal › Scientific review
-
Mark
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
- Contribution to journal › Article
-
Mark
Linear epitopes of bony fish β-parvalbumins
- Contribution to journal › Article
-
Mark
Empowering macrophages : the cancer fighters within the tumour microenvironment in mantle cell lymphoma
- Contribution to journal › Article
